ASST Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Net Income	-223.39	-21.58	-16.91
Depreciation & Amortization	0.19	0.17	0.07
Other Amortization	0.02	0.02	0.02
Loss (Gain) From Sale of Investments	0.13	-0.01	-0.08
Other Operating Activities	19.64	-0.21	0.11
Change in Accounts Receivable	-	-	0.01
Change in Accounts Payable	4.02	0.93	0.22
Change in Other Net Operating Assets	-6.06	-0.91	0.13
Operating Cash Flow	-38.24	-21.6	-16.42
Capital Expenditures	0.18	-0.02	-0.97
Investment in Securities	24.89	-3.18	1.5
Investing Cash Flow	-649.74	-3.2	0.53
Financing Cash Flow	793.28	28.86	5
Net Cash Flow	105.3	4.07	-10.88
Free Cash Flow	-38.06	-21.62	-17.39
Free Cash Flow Margin	-690.51%	-592.30%	-709.83%
Free Cash Flow Per Share	-15.96	-195.35	-166.01
Levered Free Cash Flow	-	-12.52	-
Unlevered Free Cash Flow	-	-12.52	-
Change in Working Capital	-2.04	0.02	0.36

Updated Oct 10, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q